PepGen Announces Pricing of $100 Million Public Offering
-
最新报道：PepGen Inc. has priced an underwritten public offering of 31.25 million shares at $3.20 per share, aiming to raise $100 million gross proceeds. The offering, managed by Leerink Partners and Stifel, is expected to close on September 26, 2025. Proceeds will fund clinical trials including FREEDOM-DM1 and general corporate purposes.
下一篇
KalVista Prices Upsized Offering of $125.0 Million of 3.250% Convertible Senior Notes Due 2031
- KalVista Pharmaceuticals has priced its $125 million private placement of 3.250% convertib...
24小时热点
热点专题
418154